Abzena PLC (ABZA)

Currency in GBP
15.75
0.00(0.00%)
Closed·
Showing Abzena PLC historical data. For real-time data please try another search
Day's Range
15.7515.75
52 wk Range
0.0015.75
Key Statistics
Prev. Close
15.75
Open
15.75
Day's Range
15.75-15.75
52 wk Range
0-0
Volume
-
Average Volume (3m)
85.61K
1-Year Change
0%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Strong Buy

Abzena PLC Company Profile

Abzena Limited provides contract research, development, and manufacturing services for biologics and bioconjugates, supporting drug discovery, development, and GMP manufacturing from early research through to commercial production. The company delivers integrated drug design, development, and GMP manufacturing services for biologics, bioconjugates, and antibody-drug conjugates, covering the full lifecycle from discovery to commercial production. Services include antibody discovery, lead selection and optimization, developability assessments, and formulation development for therapeutic molecules such as peptides, proteins, monoclonal antibodies, and ADCs. The company develops synthetic routes for cytotoxins, payloads, linkers, and highly potent active pharmaceutical ingredients, and provides analytical method development and testing for bioconjugate formulation. Facilities support early discovery, design, development, and commercial manufacturing across mammalian, microbial, and bioconjugate modalities, with both predefined and tailored work packages available. The company serves pharmaceutical and biotechnology companies involved in the development and commercialization of biologic drugs, bioconjugates, and antibody drug conjugates, as well as clients seeking contract research, development, and manufacturing services for novel treatments. The company was founded in 2014 and is based in Cambridge, United Kingdom.

Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Jun 04, 2018
EPS / Forecast
-0.03 / --
Revenue / Forecast
12.31M / --
EPS Revisions
Last 90 days

ABZA Income Statement

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.